“Point being, the FDA knows Leronlimab well at t
Post# of 148169
(Total Views: 429)
Posted On: 03/03/2020 9:10:28 AM
Re: Evil Rabbit #19982
“Point being, the FDA knows Leronlimab well at this stage. They know it’s safe and they’re familiar with its MOA.
Yes, exactly why the FDA has expedited the BLA process, because they “know leronlimab.” How could I have forgotten? Oh, wait.....
“I doubt NP woke up one day and thought “Hey, I know we only have preliminary data from a couple of patients but, what the hell, let’s go for it.”
You’re under estimating the master of over estimating and over promising. I don’t doubt that NP saw the results from patient #1 and his MiL and immediately felt CYDY should file for BTD. If I had time, I’d go through all the videos from the beginning of 2019 until now and write all the empty promises and statements that NP has made, from licensing, to cancer, to the prostate test, non-dilutive financing and so on.
Yes, exactly why the FDA has expedited the BLA process, because they “know leronlimab.” How could I have forgotten? Oh, wait.....
“I doubt NP woke up one day and thought “Hey, I know we only have preliminary data from a couple of patients but, what the hell, let’s go for it.”
You’re under estimating the master of over estimating and over promising. I don’t doubt that NP saw the results from patient #1 and his MiL and immediately felt CYDY should file for BTD. If I had time, I’d go through all the videos from the beginning of 2019 until now and write all the empty promises and statements that NP has made, from licensing, to cancer, to the prostate test, non-dilutive financing and so on.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼